SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-136576
Filing Date
2020-05-08
Accepted
2020-05-07 19:54:32
Documents
1
Effectiveness Date
2020-05-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A d884807ddefa14a.htm DEFA14A 21091
  Complete submission text file 0001193125-20-136576.txt   22249
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30171 | Film No.: 20858286
SIC: 2836 Biological Products, (No Diagnostic Substances)